Self-employment, sickness absence, and disability pension in multiple sclerosis.


Journal

Acta neurologica Scandinavica
ISSN: 1600-0404
Titre abrégé: Acta Neurol Scand
Pays: Denmark
ID NLM: 0370336

Informations de publication

Date de publication:
Sep 2022
Historique:
revised: 02 06 2022
received: 10 01 2022
accepted: 14 06 2022
pubmed: 6 7 2022
medline: 5 8 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

Early withdrawal from work is common among people with multiple sclerosis (PwMS). However, little is known about how this is influenced by the type of employment. The aims were to explore the distributions of self-employed and other types of employment (employed or no earnings from work) before and after MS diagnosis and its associations with sickness absence (SA) and disability pension (DP) among PwMS and matched references without MS. A 6-year longitudinal cohort study of 2779 individuals diagnosed with MS in 2008-2012 when aged 20-59 and of 13,863 matched individuals without MS from Sweden's population was conducted. Hazard ratios (HR) of >180 SA and/or DP days/year were compared by employment status among PwMS and references using Cox proportional hazard models with 95% confidence intervals (CI). Most had no SA or DP. Nevertheless, PwMS had higher SA and DP levels compared with references. PwMS had a higher likelihood to reach >180 days of SA (HR = 4.89, 95% CI = 4.43-5.40) or days of DP (HR = 6.31, 95% CI = 5.46-7.30), irrespective of the employment status. Self-employed references had less likelihood for >180 SA days than employed references. However, self-employed and employed PwMS had a similar likelihood for >180 SA days. Transitions of employees to self-employment were infrequent among PwMS (1.7%) and references (2.6%). PwMS transit to SA and DP to a higher extent than references. In contrast to individuals without MS, self-employed PwMS had similar SA levels to employed PwMS. Switching to self-employment was not a predominant choice for people recently diagnosed with MS.

Identifiants

pubmed: 35781876
doi: 10.1111/ane.13664
pmc: PMC9544424
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-294

Subventions

Organisme : Swedish Research Council
Organisme : Swedish Social Insurance Agency

Informations de copyright

© 2022 The Authors. Acta Neurologica Scandinavica published by John Wiley & Sons Ltd.

Références

J Neurol Sci. 2016 Aug 15;367:319-25
pubmed: 27423611
Mult Scler Relat Disord. 2020 Jul;42:102077
pubmed: 32353754
Mult Scler Relat Disord. 2019 Jun;31:32-37
pubmed: 30901702
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Mult Scler. 2010 Jan;16(1):121-6
pubmed: 20007430
Mult Scler. 2013 Oct;19(12):1647-54
pubmed: 23652213
Scand J Soc Med. 1991 Sep;19(3):148-53
pubmed: 1796246
Eur J Epidemiol. 2017 Sep;32(9):765-773
pubmed: 28983736
Acta Oncol. 2009;48(1):27-33
pubmed: 18767000
Ann Neurol. 2005 Dec;58(6):840-6
pubmed: 16283615
J Epidemiol Community Health. 2018 Oct;72(10):951-957
pubmed: 29936420
J Clin Epidemiol. 2022 Feb;142:60-99
pubmed: 34715311
BMJ Open. 2020 Dec 29;10(12):e039228
pubmed: 33376161
Mult Scler. 2013 Dec;19(14):1923-30
pubmed: 23652218
Mult Scler. 2016 Dec;22(14):1859-1866
pubmed: 27650517
Ann Neurol. 2001 Jul;50(1):121-7
pubmed: 11456302
Scand J Soc Med. 1998 Jun;26(2):133-44
pubmed: 9658514
Acta Neurol Scand. 2015;132(199):11-9
pubmed: 26046553
Eur Neuropsychopharmacol. 2012 Jan;22(1):36-43
pubmed: 21669514
Eur J Epidemiol. 2019 Apr;34(4):423-437
pubmed: 30929112
Acta Neurol Scand. 2022 Sep;146(3):283-294
pubmed: 35781876
J Health Psychol. 2019 Jan;24(1):38-51
pubmed: 28810436
BMJ Open. 2018 May 9;8(5):e020392
pubmed: 29743325
BMJ Open. 2016 Nov 17;6(11):e012731
pubmed: 27856477
J Neurol. 2020 Oct;267(10):3069-3082
pubmed: 32529580
Acta Neurol Scand. 2018 Dec;138(6):490-499
pubmed: 30043392
PLoS One. 2015 Dec 22;10(12):e0145435
pubmed: 26695832
BMJ Open. 2018 Apr 13;8(4):e021122
pubmed: 29654048
Int J MS Care. 2015 Sep-Oct;17(5):245-52
pubmed: 26472946
Eur J Epidemiol. 2016 Feb;31(2):125-36
pubmed: 26769609
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213
Basic Clin Pharmacol Toxicol. 2016 Nov;119(5):464-469
pubmed: 27112967
BMJ Open. 2019 Jul 11;9(7):e024836
pubmed: 31300492
Mult Scler. 2017 Jul;23(8):1123-1136
pubmed: 28273775
Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):726-35
pubmed: 16897791
Mult Scler. 2017 Aug;23(2_suppl):179-191
pubmed: 28643601
Int J Public Health. 2018 Jul;63(6):713-722
pubmed: 29846767
Pain. 2019 May;160(5):1224-1233
pubmed: 31009421

Auteurs

Alejandra Machado (A)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Chantelle Murley (C)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Jan Hillert (J)

Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Kristina Alexanderson (K)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Emilie Friberg (E)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH